NCT05324371View on ClinicalTrials.gov

WATCHMAN FLX™ CT Study

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 9, 2022

Primary Completion Date

May 30, 2024

Study Completion Date

January 23, 2025

Conditions
The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation
Interventions
DEVICE

Watchman FLX Device

Left atrial appendage closure using the Watchman FLX device

Trial Locations (1)

Unknown

Aarhus University Hospital, Aarhus

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY